Previously submitted to: JMIR AI (no longer under consideration since Apr 20, 2023)
Date Submitted: Jul 5, 2022
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Should we Embrace Health Data Sharing?
ABSTRACT
Patients' health data are routinely collected and stored in hospitals for care delivery. If the data is made available for researchers, it can be secondarily used for artificial intelligence research and development. Data sharing and reuse brought new ethical concerns to healthcare organizations and the medical and research communities alike. In this article, we discuss the main ethical aspects that underpin data sharing decisions: health data ownership, patient consentment, privacy, personal data anonymization, and the purpose of data reuse. Three pillars should guide organizations in data sharing decisions: regulations, ethics, and support for increasing patient engagement. Efforts should be undertaken to explain the risks, benefits, and opportunities of data sharing to patients and society at large. There is a concern that algorithms' outputs are biased, which may be a result of biased datasets. To prevent this, datasets must include a representative cross-section of the population so that discoveries and innovations are generalizable to all people. A deeper understanding of health data reuse by different stakeholders are decisive for elevating population health informatics research.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.